January 29, 2016 — Intact Vascular Inc. announced that positive six-month results from its Tack Optimized Balloon ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
At the beginning of each year, I always try to determine what the next big cardiovascular technology advances to watch ...
The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient ...
December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-Expanding ...
December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the ...
For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on ...
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies ...
Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...